| Literature DB >> 32095169 |
Mowyad Khalid1, Mazin Khalid2, Vijay Gayam2, Ahmed Yeddi1, Omeralfaroug Adam1, Sandipan Chakraborty2, Mohamed Abdallah3, Ahmad Abu-Heija1, Zaid Kaloti1, Osama Mukhtar2, Hammam Shereef4, Stephanie Judd5.
Abstract
BACKGROUND: Colonoscopy has been widely used as a diagnostic tool for many conditions, including inflammatory bowel disease and colorectal cancer. Colonoscopy complications include perforation, hemorrhage, abdominal pain, as well as anesthesia risk. Although rare, perforation is the most dangerous complication that occurs in the immediate post-colonoscopy period with an estimated risk of less than 0.1%. Studies on colonoscopy perforation risk between teaching hospitals and non-teaching hospitals are scarce.Entities:
Keywords: Colonoscopy; Hospital teaching status; Perforation
Year: 2020 PMID: 32095169 PMCID: PMC7011915 DOI: 10.14740/gr1234
Source DB: PubMed Journal: Gastroenterology Res ISSN: 1918-2805
Demographic Characteristics of Patients Who Underwent Colonoscopy Between 2010 and 2014 Stratified by Teaching vs. Non-Teaching Facilities
| Variables | Total | Non-teaching | Teaching | P value |
|---|---|---|---|---|
| No. of observations, unweighted | 257,006 | 135,652 | 121,354 | |
| No. of observations, weighted | 1,273,042 | 669,250 | 603,792 | |
| Age, mean (SD) | 68 (15) | 66 (15) | < 0.0001 | |
| Sex | ||||
| Female, N (%) | 682,062 | 365,012 (55%) | 317,050 (53%) | < 0.0001 |
| Male, N (%) | 590,655 | 304,023 (45%) | 286,632 (47%) | |
| Race | ||||
| White | 797,383 | 451,028 (72%) | 346,355 (62%) | < 0.0001 |
| Black | 215,822 | 85,997 (14%) | 129,824 (23%) | |
| Hispanic | 115,739 | 61,225 (10 %) | 54,513 (10%) | |
| Asian | 27,557 | 13,240 (2%) | 14,317 (2%) | |
| Others | 35,109 | 17,427 (2%) | 17,682 (3%) | |
| Ulcerative colitis | 10,242 | 4,869 (7%) | 5,374(9%) | < 0.0001 |
| Crohn’s disease | 17,675 | 7,870 (1.2%) | 9,805 (1.6%) | < 0.0001 |
| Polypectomy | 44,911 | 23,134 (3.4%) | 21,777 (3.6%) | 0.17 |
| Stricture | 5,443 | 2,587 (0.4%) | 2,856 (0.5%) | 0.002 |
| Insurance | ||||
| Medicare | 808,730 | 440,454 (68%) | 368,277 (63%) | < 0.0001 |
| Medicaid | 112,512 | 52,624 (8%) | 59,888 (10%) | |
| Private insurance | 259,139 | 131,034 (20%) | 128,106 (22%) | |
| Self-pay/no charge/other | 55,623 | 26,419 (4%) | 29,204 (5%) | |
| Elixhauser comorbidity index | ||||
| 0 | 59,210 | 33,157 (5%) | 26,053 (4%) | < 0.0001 |
| 1 - 3 | 346,130 | 188,437 (28%) | 157,693 (26%) | |
| ≥ 4 | 867,701 | 447,655 (67%) | 420,046 (70%) |
SD: standard deviation.
Univariate Odds Ratio for Perforation Post-Colonoscopy in Teaching Facilities Compared to Non-Teaching by Logistic Regression Model
| Variables | Crude odds ratio with confidence interval | P value |
|---|---|---|
| Perforation | 1.17 (1.02 - 1.34) | 0.02 |
| Age | 1.00 (0.99 - 1) | 0.39 |
| Female sex | 1.29 (1.12 - 1.47) | < 0.0001 |
| Ulcerative colitis | 2.67 (1.67 - 4.28) | < 0.0001 |
| Crohn’s disease | 2.71 (1.9 - 3.85) | < 0.0001 |
| Dilatation of stricture | 6.04 (3.92 - 9.31) | < 0.0001 |
| Polypectomy | 1.13 (0.81 - 1.59) | 0.47 |
| Race | 0.88 (0.82 - 0.96) | 0.005 |
| Insurance | ||
| Medicare | Referent | |
| Medicaid | 0.81 (0.62 - 1) | 0.12 |
| Private insurance | 1.04 (0.88 - 1.23) | 0.59 |
| Self-pay/no charge/other | 0.78 (0.55 - 1.13) | 0.196 |
| Elixhauser comorbidity index | ||
| 0 | Referent | |
| 1 - 3 | 0.72 (0.54 - 0.96) | 0.027 |
| ≥ 4 | 0.69 (0.52 - 0.90) | 0.008 |
Multivariate Odds Ratio for Perforation Post-Colonoscopy in Teaching Facilities Compared to Non-Teaching by Logistic Regression Model
| Variables | Adjusted odds ratio with confidence interval | P value |
|---|---|---|
| Teaching | 1.23 (1.07 - 1.42) | 0.004 |
| Female sex | 1.35 (1.16 - 1.56) | < 0.001 |
| Ulcerative colitis | 2.41 (1.46 - 3.97) | 0.001 |
| Crohn’s disease | 2.40 (1.65 - 3.51) | < 0.001 |
| Dilatation of stricture | 5.19 (3.21 - 8.39) | < 0.001 |
| Race | ||
| White | Referent | |
| African-American | 0.65 (0.53 - 0.80) | < 0.001 |
| Hispanic | 0.94 (0.74 - 1.20) | 0.62 |
| Asian | 0.98 (0.62 - 1.56) | 0.94 |
| Others | 0.45 (0.26 - 0.81) | 0.007 |
| Elixhauser comorbidity index | ||
| 0 | Referent | |
| 1 - 3 | 0.76 (0.56 - 1.05) | 0.10 |
| ≥ 4 | 0.77 (0.57 - 1.04) | 0.09 |